3Horwitz H. The genetics of familial leukemia [J ]. Leukemia, 1997, 11:1347-1359.
4Song W J,Sallivan G M,Legare D R, et al. Haploinsufficuency of CBFA2 causes familial thrombocytopenia with propensity to develenpment acute myelogenous leukemia[J]. Nat Genet, 1999,23:166-174.
5Joventino L P,Stock W,Lane N J,et al.Certain HLA antigens are associated with specific morphologic and cytogenetic subsets of acute myeloid leukemia[J]. Leukemia, 1995,9: 433-439.
6Perera F P. Environment and cancer:who are eusceptible? [J]. Science,1997,278:1068-1073.
7Larson R A,Wang Y,Banerjel M,et al.Prevalencl of the inactivating 609C→T polymorphism in the NAD (p)H:Quinone oxidoreductase (NQ01) gene in patients with primary and therapy-related myeloid leukemia [J]. Blood, 1999,94:803-807.
8Wiemels J L, Pagnamenta A, Taylor G M,et al. A lack of a functional NAD(p)H:uinonal oxidoreductase allel is selectively associated with pediatric leukemia that have MLL fusion[J]. Cancer Res,1999,59: 4095-4099.
9Naoe T, Takeyama K, Yokozawa T,et al. Analysis of genetic polymorphism in NQ01 ,GST-M1, GST-T1 and CYP3A4in 469 Japanese patients with therapyrelated leukemia/myelodysplastic synalrome and de novo acute myeloid leukemia [J]. Cli Cancer Res, 2000, 6:4091-4095.
10Felix C A,Walker A H,Lange B J,et al. Association of CYP3A4 genotypte with treatment-related leukemia [J ].Proc Natl Acad USA,1998,95:13176-13181.
3Greaves M F,Alexander F E.An infectious etiology for common acute lymphoblastic leukemia in childhood.Leukemia,1993,7:349-360.
4Sorahan T,Kinlen L J,Doll R.Cancer risks in a historical UK cohort of benzene exposed workers.Occup Environ Med,2005,62:231-236.
5Rauscher G H,Sandler D P,Poole C,et al.Family history of cancer and incidence of acute leukemia in a dults.AmJ Epidemiol,2002,156:517-526.
6Perrillat F,Clavel T,Taussent I,et al.Family cancer history and risk of childhood acute leukemia.Cancer Causes Control,2001,12:935-941.
7Rauscher G H,Sandler D P,Poole C,et al.Is family xhistory of breast cancer a marker of susceptibility to exposures in the incidence of de novo adult acute leukemia? Cancer Epidemiol Biomarkers Prey,2003,12:289-294.
8VardimanJW, ThieleJ, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neo- plasms and acute leukemia: rationale and important changes[]]. Blood, 2009, 114(5) :937-951.
9Deol A, Abrams J, Masood A, et al. Long-term follow up of pa- tients proceeding to transplant using plerixafor mobilized stem cells and incidence of secondary myelodysplastic syndrome/AML[J]. Bone Marrow Transplant, 2013, 48 (8) : 1112-1116.
10Smith SM, Le Beau MM, Huo D, et al. Clinical-cytogenetic associ- ations in 306 patients with therapy--related myelodysplasia and my- eloid leukemia: the University of Chicago series[J]. Blood, 2003, 102(1):43-52.
